 |
Articles: Drug/Product Approvals |
Prior Articles
FDA Prepares Guidance for CAD Systems
HealthDataManagement, 10/30/09
Novartis biological drug Ilaris approved in EU to treat children and adults with CAPS, a rare debilitating auto-inflammatory disease
Novartis, 10/29/09
Free full text
Shire Secures European Wide Label Extension for FOSRENOL in Chronic Kidney Disease
Shire, 10/29/09 Medtronic Launches New Neuro Oncology Surgical Imaging System Internationally
Medtronic, 10/28/09
Free full text
King Pharmaceuticals Licenses Exclusive Rights to Cyanokit in U.S
King Pharmaceuticals, 10/28/09
Free full text
GSK and Genmab receive accelerated approval for Arzerra
GlaxoSmithKline, 10/28/09
Free full text
CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam
Cryolife, 10/28/09
Free full text
Gsk and genmab receive accelerated approval for arzerra
Genmab, 10/27/09
Free full text
Genmab achieves milestone in arzerra collaboration
Genmab, 10/27/09
Free full text
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Free full text
Gileads Aztreonam for Inhalation Solution to be Reviewed by FDA Anti-Infective Drugs Advisory Committee on December 2009
Gilead, 10/27/09
Free full text
FDA Issues Early Communication About Ongoing Safety Review of Weight Loss Drug Orlistat
Gastroenterology, 10/27/09 CHMP issues positive opinion for Micardis as the first treatment in its class to reduce the risk of cardiovascular morbidity in high CV risk patients
Boehringer Ingelheim, 10/26/09
Free full text
Novartis receives approval in the European Union for Exforge HCT, a new 3-in-1 treatment for high blood pressure
Novartis, 10/26/09
Free full text
Merck and Schering-Plough Receive Approval From European Commission for Merger
Merck & Co., 10/26/09
Free full text
Zogenix and astellas announce data published showing the benefits of sumaveltm doseprotm needle-free delivery system
Astellas, 10/23/09
Free full text
Biopharmaceuticals: Approval Trends in 2008
BioPharm, 10/23/09
Free full text
Novartis delivers strong new product momentum and operational performance in first nine months of 2009
Novartis, 10/23/09
Free full text
FDA Leaders Stress Science and Compliance
BioPharm, 10/23/09
Free full text
Sanofi-aventis and Wellstat Therapeutics enter into an Exclusive Worldwide Licensing Agreement for novel oral agent to treat Type II Diabetes
Sanofi-aventis, 10/22/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
